LL-37 · research summary
bioRxiv : the preprint server for biology · 2026. Summary drawn from the study's full text. Each statement is followed by the exact sentence it comes from. This is a research summary, not medical advice.
In vitro genetic and biochemical study using Streptococcus pyogenes strains
“Using a genetic approach, we show that the presence SpeB did not significantly impact the killing of Spy by LL-37 relative to other known resistance factors.”
Streptococcus pyogenes (Group A Streptococcus) and the antimicrobial peptide LL-37
“One of the microbes with the potential to cleave LL-37 is Streptococcus pyogenes (Spy; Group A Streptococcus)9,10.”
Experiments included 2-hour exposure for survival assays and 15-hour growth for reporter measurements
“After 2 h of exposure, there was no significant difference in survival between the two strains (Fig. 2B).”
The presence of SpeB did not significantly impact the killing of Streptococcus pyogenes by LL-37 compared to other resistance factors.
“Using a genetic approach, we show that the presence SpeB did not significantly impact the killing of Spy by LL-37 relative to other known resistance factors.”
The CovRS two-component system maintains sensitivity to LL-37 fragments generated by SpeB cleavage.
“Furthermore, while SpeB cleaves LL-37, CovRS maintains sensitivity to LL-37 fragments.”
SpeB cleavage of LL-37 does not negatively impact virulence factor regulation in Streptococcus pyogenes.
“These results indicate that SpeB cleavage of LL-37 does not negatively impact virulence factor regulation in Spy.”
It remains unclear if specific regions of LL-37 mediating immune regulatory activities are destroyed by SpeB proteolysis.
“This would be informed by future studies that map whether specific regions of LL-37 mediate these activities, and if they would be destroyed by SpeB proteolysis.”
Source: PubMed 42812144 · DOI 10.64898/2026.08.12.744433 · all study summaries